CDTX - Cidara Therapeutics Inc
Cidara Therapeutics Inc Logo

CDTX - Cidara Therapeutics Inc

https://www.cidara.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Cidara Therapeutics, Inc., a biotechnology company, is focused on the discovery, development, and commercialization of new long-acting anti-infectives for the treatment and prevention of disease in the United States. The company is headquartered in San Diego, California.

52W High
$69.36
52W Low
$10.14
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.29
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
5.75
EV/EBITDA (<8 favorable)
-1.64
EV/Revenue (<3 favorable)
0.61
P/S (TTM) (<3 favorable)
4540.70
P/B (<3 favorable)
3.20
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.89%
Institutions (25–75% balanced)
107.05%
Shares Outstanding
25,358,100
Float
16,584,700
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
-108,720,000
EPS (TTM)
-7.63
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.37%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
1.6797
Previous
1.9834
Trend
Falling
Signal Cross
No cross
As of
Sep. 05, 2025